-- New kits compare broadest range of genetic data to help labs reduce evidence backlogs faster and solve crimes more cost effectively
CARLSBAD, California, Oct. 1, 2012 /PRNewswire/ -- Life Technologies Corporation – (NASDAQ: LIFE) the world's leader in human identification solutions, today launched the GlobalFiler™ Express kit, a new DNA kit that will revolutionize how crime labs perform forensic testing around the world -- making it faster, easier and cheaper to process DNA samples.
By increasing the number of genetic markers by over 30% to 24, GlobalFiler™ Express delivers the ability to recover significantly more information from forensic samples and increases discrimination power by up to 9 orders of magnitude. This results in faster and more powerful comparisons of forensic data to resolve crimes. Combined with five times faster processing efficiency, this powerful advancement will enable forensic scientists to solve and prevent more crime while addressing ever-growing backlogs. To date, 44 countries have now implemented criminal offender DNA database programs with a combined offender sample pool of 40 million and growing.
"I've been very impressed with GlobalFiler's performance," said Professor Walther Parson, Ph.D., a leading world expert in forensic DNA testing in Innsbruck, Austria. "It's extremely high discrimination power will greatly facilitate intelligence databasing and solving of national and cross-border crime."
The GlobalFiler™ kit portfolio which includes the GlobalFiler™ Express kit for reference sample processing and the GlobalFiler™ kit for casework evidence, features a new, proprietary chemistry that enables 48 samples to be processed in under two hours when combined with Life Technologies' forensic testing systems -- five times faster than other solutions currently on the market. It also facilitates quicker and improved amplification of challenging samples, such as degraded human remains. All combined, the new kits offer forensic science customers an unsurpassed standard in rapid DNA processing from sample-to-result.
For more than 25 years, Life Technologies has led the development and commercialization of the industry's most trusted and reliable forensic solutions for human identification (HID) testing. It is also the only company in the world that designs and validates its reagents, instruments and data analysis software together as an integrated system for HID testing.
"No other company understands the needs of forensic scientists better than we do and as a result, we have delivered a product that will dramatically change the way forensic testing is done on a global scale," said John Gerace, Head of Applied Sciences for Life Technologies. "We know that time and costs are of critical importance when it comes to solving crimes."
GlobalFiler™ is for forensic or paternity use only.
About Life Technologies Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum with more than 50,000 products for agricultural biotechnology, translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, GIBCO®, Ambion®, Molecular Probes®, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011. Visit us at our website: www.lifetechnologies.com.
Life Technologies' Safe Harbor Statement This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.